z-logo
open-access-imgOpen Access
Moxifloxacin Monotherapy in Left-Sided Staphylococcus aureus Endocarditis
Author(s) -
Yücel Çölkesen
Publication year - 2021
Publication title -
case reports in infectious diseases
Language(s) - English
Resource type - Journals
eISSN - 2090-6625
pISSN - 2090-6633
DOI - 10.1155/2021/5586450
Subject(s) - medicine , moxifloxacin , endocarditis , staphylococcus aureus , methicillin resistant staphylococcus aureus , regimen , antibiotics , infective endocarditis , surgery , staphylococcal infections , blood culture , microbiology and biotechnology , bacteria , genetics , biology
Staphylococcus aureus is the major cause of endocarditis, and its mortality has remained high despite therapeutic procedures over time. A case of left-sided native valve endocarditis caused by methicillin-sensitive Staphylococcus aureus which responded well to moxifloxacin monotherapy is described. An 83-year-old woman with a history of current hospitalization presented with fatigue and fever. Transthoracic echocardiography depicted vegetation, and blood cultures were positive for Staphylococcus aureus . After a 14-day intravenous administration of moxifloxacin, a good clinical response was achieved, and antibiotic regimen transitioned to oral moxifloxacin for an additional four-week therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom